Expression of CAAT Enhancer Binding Protein Beta (C/EBP β) in Cervix and Endometrium by Arnett, Brenda et al.
BioMed  Central
Page 1 of 6
(page number not for citation purposes)
Molecular Cancer
Open Access Research
Expression of CAAT Enhancer Binding Protein Beta (C/EBP β) in 
Cervix and Endometrium
Brenda Arnett1,2, Patrick Soisson2, Barbara S Ducatman1 and Peilin Zhang*1
Address: 1Department of Pathology, West Virginia University, Morgantown, WV 26506-9203, USA and 2Department of Obstetrics & Gynecology, 
West Virginia University, Morgantown, WV 26506, USA
Email: Brenda Arnett - barnett@wvu.edu; Patrick Soisson - psoisson@hsv.wvu.edu; Barbara S Ducatman - bducatman@hsc.wvu.edu; 
Peilin Zhang* - pzhang@hsc.wvu.edu
* Corresponding author    
C/EBP βcervical carcinomaendometrial carcinoma
Abstract
Background: The CCAAT element binding protein family of transcriptional factors consists of at
least six members of the basic leucine zipper DNA binding proteins that bind to the same CCAAT
palindromic DNA sequence through homo- or hetero-dimerization with the same family members.
C/EBP β has been shown to play an important role in mediating the effects of the LH/hCG in
ovarian development. C/EBP β was also found increased in ovarian cancer and correlated to ovarian
cancer progression.
Design: We assessed the C/EBP β expression pattern in the normal and neoplastic conditions of
the female genital tract by immunostaining the normal cervix – 10 cases, squamous intraepithelial
lesion (SIL)-10, invasive squamous carcinomas of cervix – 10 cases, normal endometrial tissue – 10
cases, and invasive endometrial adenocarcinomas carcinomas-10 cases. The staining pattern and
intensity were graded from 0 to 2+. Results were statistically analyzed utilizing JMP 4.1.
Results: C/EPB β expression was detected in the normal proliferative squamous, dysplastic and
malignant squamous epithelial cells. There was no statistical correlation between C/EPB β staining
in benign squamous, endocervical tissue, SIL, and squamous cancer, as the majority of all stained
positively (91%, 79%, 71% and 89%, respectively, p = 0.3448). However, endometrial carcinoma was
significantly more likely to stain positively with C/EPB β than benign endometrial glands (92% versus
3% respectively, p < 0.0001, Fisher's exact test).
Conclusion: C/EBP β is more likely to be preferentially expressed in endometrial adenocarcinoma
as compared to benign endometrial tissue. There is no difference of C/EPB β expression in
squamous neoplasia of the cervix.
Background
The CCAAT element binding protein family of transcrip-
tional factors consists of at least six members of both func-
tionally and structurally related basic leucine zipper DNA
binding proteins that bind to the same CCAAT palindro-
mic DNA sequence through homo- or heter-dimerization
with the same family members [1]. The C/EBP family
members include C/EBP α (C/EBP), C/EBP β (also known
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as NF-IL6, LAP), C/EBP γ (Ig-EBP), C/EBP δ (NF-IL6 b), C/
EBP ε (CRP-1) and C/EBP ξ (CHOP, GADD153) [1]. The
target genes of the C/EBP family members are diverse and
involve in a variety of different cell processes including
metabolism, hematopoiesis, adipogenesis, immune sys-
tem, and cancer[1]. The expression patterns of these mem-
bers within the tissues often overlap, but the function of
the each member of the C/EBP gene family shows signifi-
cant difference. C/EBP α plays critical role in terminal dif-
ferentiation of adipogenesis and hematopoiesis, and the
lack of C/EBP α in mice result in severe hypoglycemia and
postnatal death [2]. The function of C/EBP β is much dif-
ferent from those of C/EBP α. The mice lacking C/EBP β
are viable but with hematopoietic defects, immune de-
fects and the increased susceptibility to infection, because
C/EBP β was known to regulate the cytokine gene expres-
sion in macrophages and monocytes and involves in bac-
terial killing and phagocytosis [3,4]. It was also shown in
the knockout mouse model that the mice lacking C/EBP β
exhibited defective reproduction, and C/EBP β mediated
the effects of luteinizing hormone (LH/hCG) in ovarian
follicular development and corpus luteum formation in
the female reproductive tract [5].
Despite of extensive studies of C/EBP functions in tissue
culture and mice, the link of C/EBPs to human diseases is
sparse except that the C/EBP ζ (CHOP, GADD53) is
known to involve in t(12;16)(q13;p11) in myxoid liposa-
rcoma [6]. A few studies to link the C/EBP β expression in
human cancers showed that the expression levels of C/
EBP β correlated with ovarian epithelial cancer progres-
sion and invasiveness of colorectal cancer [7,8]. Since LH
plays critical role in development and function of the ova-
ry and LH is a pituitary peptide trophic hormone regulat-
ing the steroid hormone production, we would like to
know if C/EBP β directly involves and regulates the prolif-
eration of the cervix and the endometrium. We sought to
expand the C/EBP β expression to human cervical and en-
dometrial cancers and reported here the expression pat-
tern of C/EBP β in normal cervix, endometrium, cervical
and endometrial carcinomas.
Results
We have performed the immunostains for C/EBPβ in cer-
vix and endometrium to determine if there is any change
in expression in normal cervix, dysplastic cervix, and inva-
sive cervical carcinoma. We also determine if there is any
change in expression in normal and endometrial carcino-
ma. We stained 10 cases of cervical dysplasia, 10 cases of
cervical invasive squamous carcinoma, 10 cases of benign
cervices from hysterectomy specimens for leiomyomas,
10 cases of benign normal endometrium from hysterecto-
my for leiomyomas and 10 cases of endometrial carcino-
ma. C/EBP βis present in normal proliferating cervical
squamous epithelial cells, namely, the suprabasal layers
(Figure 1). The superficial layer (the most mature layer,
equivalent to cornified layer of the skin) did not express
C/EBP β. Surprisingly, although the basal layer of the sq-
uamous epithelium of the cervix also proliferates, the ba-
sal layer did not express C/EBP β. In addition, the C/EBP
β is present in the endocervical glandular epithelium (Fig-
ure 1). A few scattered endocervical stromal cells also ex-
press C/EBP β, suggesting that there is a stromal
proliferation during the normal menstrual cycle. There is
strong staining signal within the squamous metaplastic
cells within the endocervical glands (Figure 1). There was
strong staining signal in the squamous dysplastic epitheli-
um and invasive squamous carcinoma cells. No difference
in expression patterns in dysplastic squamous epithelial
cells or cervical carcinoma cells (both in-situ and invasive)
was seen. There was no statistically significant difference
in expression of C/EBP β between dysplastic and invasive
squamous epithelial cells (Fisher's exact test). However,
the absolute number of stained cells was found to be sig-
nificantly more in the cancer specimens, which may re-
flect the higher percentage of cells in proliferative phase
compared with the normal cervical epithelium.
Endometrium also expresses C/EBP β. In the normal pro-
liferative endometrial tissues, the expressions of C/EBP β
were primarily restricted within the epithelial cells (Figure
2). Rare staining signals were seen within the endometrial
stromal cells. The level of staining intensities in the weakly
proliferative endometrial epithelial cells was relatively
low, and the staining signal was weak (1+). In prolifera-
tive endometrium, the level of expression was increased,
but still much less than those seen in the malignant epi-
thelial cells. In the endometrial carcinoma, the staining
signal was strongest (2+). Statistically, endometrial carci-
noma was significantly more likely to stain positively with
C/EPB β than benign inactive endometrial glands (92%
versus 3 % respectively, p < 0.0001, Fisher's exact test).
Discussion
We have studied the expression pattern of C/EBP β in nor-
mal, dysplastic and malignant cervical epithelial cells. It is
known that C/EBP β is important in epithelial differentia-
tion, and the expression of C/EBP βinhibited the keratino-
cyte growth and promoted differentiation [9]. Our study
that the C/EBP β expression was present in the proliferat-
ing, not resting or matured epithelial cells appears consist-
ent with the previous observation in rodent keratinocytes
[9]. Proliferation of cervical epithelium is known to be de-
pendent on the presence of estrogen, and production of
estrogen is dependent upon the stimulation of LH from
the pituitary. C/EBP β was shown to be critical for ovarian
follicular development and mediated the LH effect in the
luteal cells [5]. It is possible that C/EBP β regulates the re-
productive process at two different levels. It is interesting
to note that in the resting epithelial cells, such as the basalMolecular Cancer 2003, 2 http://www.molecular-cancer.com/content/2/1/21
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Figure 1
Expression pattern of C/EBP β in benign, dysplastic and malignant cervical tissues. Benign cervical tissues include normal, squa-
mous metaplasia, endocervical glandular epithelial cells and stromal cells. Dysplastic and invasive carcinoma tissues are listed. 
The microphotographs were taken at the magnification of 400X.Molecular Cancer 2003, 2 http://www.molecular-cancer.com/content/2/1/21
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layer of cervical cells, which is known to serve as reserve
cells, C/EBP β was not detected. The basal layer of cervical
squamous cells serve as "stem cells" for the squamous ep-
ithelium, and these cells are known to express PCNA and
p63 [10,11]. However, C/EBP β was only detected in the
proliferating cells (suprabasal cells), but not in the basal
cells. It is reasonable to assume that C/EBP β is not re-
quired for the phenotypic transition from the reserve cells
to the more differentiated cells, but plays some unclear
roles after the differentiation process is initiated.
We have found that C/EBP β was detected in the normal
proliferative endometrium, but scarce in the inactive or
weakly proliferative endometrium. Endometrium prolif-
eration is estrogen dependent under physiologic condi-
tions, and it appears that there is a correlation between the
estrogen effect and the expression of C/EBP β in prolifera-
tion of the endometrium, although such correlation was
not established at the molecular level.
Under dysplastic or malignant conditions, the expression
C/EBP β was abundant in both cervical and endometrial
tissues. Cervical cancer is related to the human papilloma
viral infection, especially high risk HPV groups, such as
HPV 16 and 18 subtypes [12]. It has been reported that C/
EBP β can directly bind to the regulatory region of HPV 18
viral genome and control the expression of E6 and E7 on-
coproteins of the HPV in cell-specific manner [13]. It is
possible that high level of C/EBP β expression in the cer-
vical cancer facilitate the viral replication in the cervical
cancer cells.
High expression level of C/EBP β was also detected in the
endometrial cancer cells. It has been reported that C/EBP
β repressed the P450 aromatase gene expression in the en-
dometrial epithelial and stromal cells, and plays impor-
tant roles in endometriosis [14].
Finally, the expression of C/EBP β appears to serve as an
important proliferating marker for both the cervical and
endometrial cancers, since C/EBP β only expressed in pro-
liferative cancer cells. Several other proliferation markers,
such as Ki-67, PCNA and p63, had been successfully ap-
plied to pathologic diagnosis and used as a prognostic fac-
tor [10,11]. It is possible that the expression of C/EBP β
can be used as a prognostic marker for both cervical and
endometrial cancers. More studies are required to estab-
lish the link between the expression pattern of C/EBP β
and the prognosis of the cervical and the endometrial can-
cer patients.
Materials and methods
Patients' materials
We have retrieved totally 50 cases of surgically resected
specimens from the paraffin-embedded tissue archive in
Department of Pathology. These 50 cases included 10 cas-
es of normal cervical tissues and 10 cases of endometrial
tissues derived from the patients of benign leiomyomas.
There was no documented record of malignant or dysplas-
tic changes within these specimens. Also included were 10
cases of high-grade cervical dysplasia (CIN II-III), 10 cases
of invasive squamous carcinoma of the cervix, and 10 cas-
es of endometrial adenocarcinoma. The clinical diagnoses
were previously unequivocally made within the depart-
ment of Pathology at the West Virginia University.
Figure 2
Expression pattern of C/EBP β in benign and malignant endometrium. Normal proliferative endometrium, weakly proliferative/
inactive endometrium and invasive endometrial carcinoma were listed. The photographs were taken at the magnification of 
400X.Molecular Cancer 2003, 2 http://www.molecular-cancer.com/content/2/1/21
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Immunoperoxidase staining and data analyses
The study was internally reviewed and approved by the In-
stitutional review Board (IRB) at the West Virginia Univer-
sity. The paraffin blocks were retrieved, sectioned at 5
micron in thickness, and subjected to manipulation for
immunostaining using Ventana Benchmark automated
immunostainer (Ventana, AZ) following the instruction
from the manufacturer. The antigen retrieval solution and
immunostaining reagents were all from the Ventana Inter-
nationals (Tucson, AZ). The anti-C/EBP β antibody is
from Santa Cruz Biotechnologies (Santa Cruz, CA). The
primary antibody was used 1:200 dilution, and immunos-
taining signals were detected by peroxidase methods. The
slides were reviewed by two independent pathologists,
and the intensities of the staining signals were semi-quan-
titatively scored at 0, 1+ and 2+, with 0 being no staining,
1+ being weak in intensity, and stains no more than 10%
of the epithelial cells, and 2+ being strong with more than
10% cell staining. Since C/EBP β is a transcriptional fac-
tor, and normally only expressed in nuclei, the cytoplas-
mic and membrane staining patterns were interpreted as
non-specific (negative) signals. The results are summa-
rized as the following in Table 1. The staining data were
collected, and analyzed using computer software JMP 4.1
from SAS Inc. USA.
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